未登录

C

Christopher Foley

University of Arizona

H指数:14

被引数:907

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery and Functional Characterization of a Potent, Selective, and Metabolically Stable PROTAC of the Protein Kinases DYRK1A and DYRK1B

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-09-300

PRE

A novel immunotherapy for relapsed/refractory acute lymphoblastic leukemia (ALL)

CANCER RESEARCH

IF16.6

2023-04-040

PRE

DYRK1A antagonists rescue degeneration and behavioural deficits of in vivo models based on amyloid-β, Tau and DYRK1A neurotoxicity

SCIENTIFIC REPORTS

IF3.9

2022-09-238

OAAI

Sequential Knoevenagel [4+1] Cycloaddition-Condensation-Aza-Friedel-Crafts Intramolecular Cyclization: A 4-Center-3-Component Reaction Toward Tunable Fluorescent Indolizine Tetracycles

JOURNAL OF ORGANIC CHEMISTRY

IF3.6

2021-11-248

PREAI

Suzuki Coupling of Protected Aryl Diazonium Ions: Expanding the Knowledge of Triazabutadiene Compatible Reactions

ORGANIC LETTERS

IF5

2021-02-117

OAAI

5-Endo Trig Oxidative Radical Cyclizations of Ugi-3CR Products toward 1,4-Imidazolidinones

ORGANIC LETTERS

IF5

2020-12-1112

PREAI

Androgen Receptor Is the Key Transcriptional Mediator of the Tumor Suppressor SPOP in Prostate Cancer (vol 74, pg 5631, 2014)

CANCER RESEARCH

IF16.6

2019-09-032

PREAI

Exploring Ugi-Azide Four-Component Reaction Products for Broad-Spectrum Influenza Antivirals with a High Genetic Barrier to Drug Resistance

SCIENTIFIC REPORTS

IF3.9

2018-03-1530

OAAI

Aza-Riley Oxidation of Ugi-Azide and Ugi-3CR Products toward Vicinal Tricarbonyl Amides: Two-Step MCR-Oxidation Methodology Accessing Functionalized α,β-Diketoamides and α,β-Diketotetrazoles

ORGANIC LETTERS

IF5

2018-02-2127

OAAI

Dyrk1 inhibition improves Alzheimer's disease-like pathology

IF7.1

2017-08-0489

OAAI

A novel approach for targeting androgen receptor signaling axis in prostate cancer

CANCER RESEARCH

IF16.6

2017-07-010

PRE

SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein

IF7.3

2017-04-17100

OAAI

Oxidative Deaminations and Deisatinylations of Ugi-Azide and Ugi-3CR Products: A Two-Step MCR-Oxidation Protocol toward Functionalized α-Ketoamides and α-Ketotetrazoles

ORGANIC LETTERS

IF5

2017-04-1416

PREAI

Two-Step Route to Diverse N-Functionalized Peptidomimetic-like Isatins through an Oxidation/Intramolecular Oxidative-Amidation Cascade of Ugi Azide and Ugi Three-Component Reaction Products

ORGANIC LETTERS

IF5

2016-09-1531

PREAI

Androgen Receptor Is the Key Transcriptional Mediator of the Tumor Suppressor SPOP in Prostate Cancer

CANCER RESEARCH

IF16.6

2014-09-30157

OAAI